FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310079286> ?p ?o ?g. }

• W4310079286 endingPage "e852" @default.
• W4310079286 startingPage "e842" @default.
• W4310079286 abstract "Background Prospective data about the risks of thrombotic and severe haemorrhagic complications during pregnancy and post partum are unavailable for women with antiphospholipid syndrome. We aimed to assess thrombotic and haemorrhagic events in a prospective cohort of pregnant women with antiphospholipid syndrome. Methods This multicentre, prospective, observational study was done at 76 centres in France. To be eligible for this study, women had to have diagnosis of antiphospholipid syndrome; have conceived before April 17, 2020; have an ongoing pregnancy that had reached 12 weeks of gestation; and be included in the study before 18 weeks of gestation. Exclusion criteria were active systemic lupus erythematosus nephropathy, or a multifetal pregnancy. Severe haemorrhage was defined as the need for red blood cell transfusion or maternal intensive care unit admission because of bleeding or invasive procedures, defined as interventional radiology or surgery, to control bleeding. The GR2 study is registered with ClinicalTrials.gov, NCT02450396. Findings Between May 26, 2014, and April 17, 2020, 168 pregnancies in 27 centres met the inclusion criteria for the study. 89 (53%) of 168 women had a history of thrombosis. The median term at inclusion was 8 weeks gestation. 16 (10%) of 168 women (95%CI 5–15) had a thrombotic (six [4%] women; 95% CI 1–8) or severe haemorrhagic event (12 [7%] women; 95% CI 4–12). There were no deaths during the study. The main risk factors for thrombotic events were lupus anticoagulant positivity at inclusion (six [100%] of six women with thrombosis vs 78 [51%] of 152 of those with no thrombosis; p=0·030) and placental insufficiency (four [67%] of six women vs 28 [17%] of 162 women; p=0·013). The main risk factors for severe haemorrhagic events were pre-existing maternal hypertension (four [33%] of 12 women vs 11 [7%] of 156 women; p=0·014), lupus anticoagulant positivity at inclusion (12 [100%] of 12 women vs 72 [49%] of 146 women; p<0·0001) and during antiphospholipid history (12 [100%] of 12 women vs 104 [67%] of 156 women; p=0·019), triple antiphospholipid antibody positivity (eight [67%] of 12 women vs 36 [24%] of 147 women; p=0·0040), placental insufficiency (five [42%] of 12 women vs 27 [17%] of 156 women; p=0·038), and preterm delivery at 34 weeks or earlier (five [45%] of 11 women vs 12 [8%] of 145 women; p=0·0030). Interpretation Despite treatment adhering to international recommendations, a proportion of women with antiphospholipid syndrome developed a thrombotic or severe haemorrhagic complication related to pregnancy, most frequently in the post-partum period. Lupus anticoagulant and placental insufficiency were risk factors for these life-threatening complications. These complications are difficult to prevent, but knowledge of the antenatal characteristics associated with them should increase awareness and help physicians manage these high-risk pregnancies. Funding Lupus France, association des Sclérodermiques de France, association Gougerot Sjögren, Association Francophone contre la Polychondrite chronique atrophiante, AFM-Telethon, the French Society of Internal Medicine and Rheumatology, Cochin Hospital, the French Health Ministry, FOREUM, the Association Prix Veronique Roualet, and UCB." @default.
• W4310079286 created "2022-11-30" @default.
• W4310079286 creator A5000032925 @default.
• W4310079286 creator A5000215110 @default.
• W4310079286 creator A5000732735 @default.
• W4310079286 creator A5001922824 @default.
• W4310079286 creator A5002179108 @default.
• W4310079286 creator A5003360902 @default.
• W4310079286 creator A5003665382 @default.
• W4310079286 creator A5003714626 @default.
• W4310079286 creator A5005578041 @default.
• W4310079286 creator A5005692165 @default.
• W4310079286 creator A5005724252 @default.
• W4310079286 creator A5005977398 @default.
• W4310079286 creator A5006258019 @default.
• W4310079286 creator A5006659055 @default.
• W4310079286 creator A5007071102 @default.
• W4310079286 creator A5007247451 @default.
• W4310079286 creator A5007974437 @default.
• W4310079286 creator A5009239755 @default.
• W4310079286 creator A5010018988 @default.
• W4310079286 creator A5010398306 @default.
• W4310079286 creator A5011296918 @default.
• W4310079286 creator A5011501912 @default.
• W4310079286 creator A5011616949 @default.
• W4310079286 creator A5012344363 @default.
• W4310079286 creator A5012684449 @default.
• W4310079286 creator A5012917558 @default.
• W4310079286 creator A5013089936 @default.
• W4310079286 creator A5013542885 @default.
• W4310079286 creator A5015216785 @default.
• W4310079286 creator A5016242138 @default.
• W4310079286 creator A5018486655 @default.
• W4310079286 creator A5018755487 @default.
• W4310079286 creator A5019036358 @default.
• W4310079286 creator A5019174888 @default.
• W4310079286 creator A5019609464 @default.
• W4310079286 creator A5020645373 @default.
• W4310079286 creator A5022629759 @default.
• W4310079286 creator A5024179438 @default.
• W4310079286 creator A5024220480 @default.
• W4310079286 creator A5025824766 @default.
• W4310079286 creator A5026224054 @default.
• W4310079286 creator A5027134318 @default.
• W4310079286 creator A5029064759 @default.
• W4310079286 creator A5029642865 @default.
• W4310079286 creator A5030195750 @default.
• W4310079286 creator A5031821767 @default.
• W4310079286 creator A5031918378 @default.
• W4310079286 creator A5032410461 @default.
• W4310079286 creator A5033347563 @default.
• W4310079286 creator A5033498204 @default.
• W4310079286 creator A5035751362 @default.
• W4310079286 creator A5035754619 @default.
• W4310079286 creator A5036285321 @default.
• W4310079286 creator A5036313688 @default.
• W4310079286 creator A5036332378 @default.
• W4310079286 creator A5036343171 @default.
• W4310079286 creator A5037025760 @default.
• W4310079286 creator A5037636780 @default.
• W4310079286 creator A5037857352 @default.
• W4310079286 creator A5039168250 @default.
• W4310079286 creator A5039264064 @default.
• W4310079286 creator A5039798351 @default.
• W4310079286 creator A5040022818 @default.
• W4310079286 creator A5040536603 @default.
• W4310079286 creator A5041077575 @default.
• W4310079286 creator A5041375460 @default.
• W4310079286 creator A5041733387 @default.
• W4310079286 creator A5041902083 @default.
• W4310079286 creator A5042239113 @default.
• W4310079286 creator A5042775524 @default.
• W4310079286 creator A5043705847 @default.
• W4310079286 creator A5043815214 @default.
• W4310079286 creator A5045360121 @default.
• W4310079286 creator A5045758168 @default.
• W4310079286 creator A5046042755 @default.
• W4310079286 creator A5046263391 @default.
• W4310079286 creator A5046724891 @default.
• W4310079286 creator A5047552009 @default.
• W4310079286 creator A5049103934 @default.
• W4310079286 creator A5049169527 @default.
• W4310079286 creator A5050659517 @default.
• W4310079286 creator A5051352892 @default.
• W4310079286 creator A5052832810 @default.
• W4310079286 creator A5053415776 @default.
• W4310079286 creator A5053552280 @default.
• W4310079286 creator A5053990429 @default.
• W4310079286 creator A5054024765 @default.
• W4310079286 creator A5054714771 @default.
• W4310079286 creator A5056136082 @default.
• W4310079286 creator A5057293702 @default.
• W4310079286 creator A5057595012 @default.
• W4310079286 creator A5058499860 @default.
• W4310079286 creator A5059177721 @default.
• W4310079286 creator A5059256161 @default.
• W4310079286 creator A5059449597 @default.
• W4310079286 creator A5060186682 @default.

• next